![Dagens aktienyheder 18. juli 2024: BioPorto og Pharma Equity Group](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/1117a44e-38eb-4509-8be6-d8c94054c5cf.png)
Pharma Equity Group
0,29 DKK -3,33%HC Andersen Capital modtager betaling fra Pharma Equity Group for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.
12 investorer følger denne virksomhed
Pharma Equity Group udvikler nye lægemidler til lokalbehandling af alvorlige og livstruende betændelsessygdomme hvor der i dag ikke findes en tilstrækkelig behandling. Selskabet benytter sig af repositionering af eksisterende lægemidler og fører lægemiddelkandidater frem til et klinisk fase III stadie hvorefter det overgives til en strategisk partner, der vil færdigudvikle produkterne og bringe dem på markedet, enten selvstændigt eller i samarbejde med selskabet.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Copenhagen
PEG
Daglig lav / høj pris
0,279 / 0,301
DKK
Markedsværdi
296,66 mio. DKK
Aktieomsætning
169,89 t DKK
Volumen
592 t
Seneste analyser
Extensive report
Inderes' extensive report is an investor's handbook on customer companies covered by our research.
The latest extensive report was released
Read the reportAnalyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Delårsrapport
16.08.2024
Delårsrapport
15.11.2024
ViserAlle indholdstyper
![Dagens aktienyheder 18. juli 2024: BioPorto og Pharma Equity Group](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/1117a44e-38eb-4509-8be6-d8c94054c5cf.png)
The Board of Directors' decision to issue convertible loans
Bestyrelsens beslutning om udstedelse af konvertible lån
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Storaktionærmeddelelse - Pharma Equity Group A/S
Major shareholder announcement - Pharma Equity Group A/S
Major shareholder announcement - Pharma Equity Group A/S
Storaktionærmeddelelse - Pharma Equity Group A/S
![Pharma Equity Group – Opdatering på 2. kvartal 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f5b1119e-c5b5-471a-b7eb-9b5f5692944d.png)
Pharma Equity Group – Opdatering på 2. kvartal 2024
![HCA Capital: Wrap up from 2024 Life Science seminar](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
HCA Capital: Wrap up from 2024 Life Science seminar
![Life Science seminar 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
Life Science seminar 2024
Results of extraordinary general meeting in Pharma Equity Group A/S
Forløb af ekstraordinær generalforsamling i Pharma Equity Group A/S
![Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/8e35221b-ab03-4e96-85e7-32c5d1f6cfe4.png)
Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech
![Pharma Equity Group: Colorektal Cancer & Polypper](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/e63e4a03-8498-4f91-be79-24be09bcc666.png)
Pharma Equity Group: Colorektal Cancer & Polypper
![Pharma Equity Group: Investors appreciate eventful, and mostly positive, 1. quarter 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/e63e4a03-8498-4f91-be79-24be09bcc666.png)
Pharma Equity Group: Investors appreciate eventful, and mostly positive, 1. quarter 2024
Bestyrelsens beslutning om udstedelse af konvertible lån
The Board of Director's decision to issue convertible loans
![Pharma Equity Group – Opdatering på 1. Kvartal 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f5b1119e-c5b5-471a-b7eb-9b5f5692944d.png)
Pharma Equity Group – Opdatering på 1. Kvartal 2024
![Dagens aktienyheder 16/05: Ascelia Pharma, Expres2ion Biotechnologies, Nordic Solar, Pharma Equity Group](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/c21580e9-17e8-470c-b245-33c782a3e9c8.png)